查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1404820

疫苗佐剂市场规模、份额、趋势分析报告：按类型、给药、应用、地区、细分市场预测，2023-2030

Vaccine Adjuvants Market Size, Share & Trends Analysis Report By Type (Pathogen, Adjuvant Emulsion, Particulate), By Administration (Oral, Intradermal, Intranasal, Intramuscular), By Application, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

疫苗佐剂市场成长与趋势：

Grand View Research, Inc. 的最新报告显示，到 2030 年，全球疫苗佐剂市场预计将达到 19 亿美元。

预计 2023 年至 2030 年该市场将以 2.3% 的复合年增长率成长。创新疫苗抗原的免疫抗原性不足，逐渐提高了佐剂研究在疫苗研发中的重要性。此外，对现有和新出现疾病的持久免疫力的关注预计也将推动对疫苗佐剂的需求。

此外，子宫颈癌盛行率的上升预计将提振市场。根据 NCBI 统计，每年约有 15,000 名女性死于子宫颈癌。一些公司，例如葛兰素史克的 AS04 佐剂（人类乳突病毒疫苗），正在开发能够更长时间增强免疫反应的佐剂。

疫苗佐剂市场报告亮点

  • 疫苗佐剂市场依类型分为佐剂乳液、病原体、微粒、组合药物等。 2022 年，颗粒物细分市场占据最大的市场占有率。
  • 2022年，感染疾病业务占最大收益占有率，达68.1%。这一巨大比例是由于疟疾、流感、甲型肝炎、乙型肝炎和丙型肝炎等感染疾病的盛行率逐渐增加。
  • 给药部分分为口服、皮内、鼻内、肌肉内等。由于有较好的免疫特异性，2022年给药领域的收益占有率最大，达33.8%。
  • 北美地区主导市场，2022 年收益占有率最大，为 41.7%。北美市场的成长是由新疗法研发投资的增加以及致命传染病数量的增加所推动的。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章疫苗佐剂市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 普及和成长前景图
  • 市场动态
    • 市场驱动因素分析
    • 市场抑制因素分析
  • 疫苗佐剂市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第4章 疫苗佐剂：类型估计与趋势分析

  • 疫苗佐剂市场：要点
  • 疫苗佐剂市场：2022 年和 2030 年趋势和市场占有率分析
  • 病原
  • 佐剂乳化
  • 细颗粒
  • 组合
  • 其他的

第五章 疫苗佐剂：使用量估算及趋势分析

  • 疫苗佐剂市场：要点
  • 疫苗佐剂市场：2022 年和 2030 年趋势和市场占有率分析
  • 感染疾病
  • 癌症
  • 其他的

第6章 疫苗佐剂：给药的估计与趋势分析

  • 疫苗佐剂市场：要点
  • 疫苗佐剂市场：2022 年和 2030 年趋势和市场占有率分析
  • 口服
  • 皮内
  • 鼻内
  • 肌肉注射
  • 其他的

第七章疫苗佐剂市场：区域估计与趋势分析

  • 区域展望
  • 按地区分類的疫苗佐剂市场：要点
  • 北美洲
    • 2018-2030 年市场估计与预测
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章竞争形势

  • 主要市场参与企业的最新趋势和影响分析
  • 市场参与企业分类
    • GSK
    • Novartis/CSL
    • Agenus
    • Adjuvance
    • Novavax
    • SPI Pharma
    • Invivogen
    • Avanti Polar Lipids
    • Brentagg
Product Code: GVR-1-68038-612-7

Vaccine Adjuvants Market Growth & Trends:

The global vaccine adjuvants market is expected to reach USD 1.9 billion by 2030, according to a new report by Grand View Research, Inc. The market is anticipated to grow at a CAGR of 2.3% from 2023 to 2030. The significance of adjuvant research in the development of vaccines has increased gradually due to inadequate immunogenicity of innovative vaccine antigens. In addition, the growing focus on long-lasting immunization effect against existing and emerging diseases is expected to boost the demand for vaccine adjuvants.

Furthermore, rising prevalence of cervical cancer is anticipated to boost the market. According to NCBI, around 15,000 females die every year due to cervical cancer. There are certain companies developing vaccine adjuvants for this type of cancer in order to enhance the efficacy, such as AS04 adjuvant-adsorbed (human papillomavirus vaccine) by GSK, which boosts the immune response for a longer duration.

Vaccine Adjuvants Market Report Highlights:

  • The vaccine adjuvants market is segmented based on type into an adjuvant emulsion, pathogen, particulate, combination, and others. The particulate segment held the largest market share in 2022.
  • The infectious diseases segment accounted for the largest revenue share of 68.1% in 2022. This large share can be attributed to the gradually growing prevalence of infectious diseases, such as malaria, influenza, hepatitis A, B, & C, and others.
  • The administration segment is categorized into oral, intradermal, intranasal, intramuscular, and others. Due to better immune specificity, the intramuscular segment accounted for the largest revenue share of 33.8% in 2022
  • North America dominated the market and accounted for the largest revenue share of 41.7% in 2022. The factors contributing to the growth of the market in the North American region are a rise in investments for R&D of new therapeutics and an increase in fatal epidemic diseases.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Type
    • 1.1.2. Application
    • 1.1.3. Administration type
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline.
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database.
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Application outlook
    • 2.2.3. Administration outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Vaccine Adjuvants Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
    • 3.3.2. Market Restraint Analysis
  • 3.4. Vaccine Adjuvants Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic Landscape

Chapter 4. Vaccine Adjuvants: Type Estimates & Trend Analysis

  • 4.1. Vaccine Adjuvants Market: Key Takeaways
  • 4.2. Vaccine Adjuvants Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Pathogen
    • 4.3.1. Pathogen market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Adjuvant emulsion
    • 4.4.1. Adjuvant emulsion market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Particulate
    • 4.5.1. Particulate market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. Combination
    • 4.6.1. Combination market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.7. Others
    • 4.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Vaccine Adjuvants: Application Estimates & Trend Analysis

  • 5.1. Vaccine Adjuvants Market: Key Takeaways
  • 5.2. Vaccine Adjuvants Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Infectious diseases
    • 5.3.1. Infectious diseases market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Cancer
    • 5.4.1. Cancer market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Others
    • 5.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Vaccine Adjuvants: Administration Estimates & Trend Analysis

  • 6.1. Vaccine Adjuvants Market: Key Takeaways
  • 6.2. Vaccine Adjuvants Market: Movement & Market Share Analysis, 2022 & 2030
  • 6.3. Oral
    • 6.3.1. Oral market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.4. Intradermal
    • 6.4.1. Intradermal market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. Intranasal
    • 6.5.1. Intranasal market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.6. Intramuscular
    • 6.6.1. Intramuscular market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.7. Others
    • 6.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Vaccine Adjuvants Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Outlook
  • 7.2. Vaccine Adjuvants Market by Region: Key Takeaways
  • 7.3. North America
    • 7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.3. France
      • 7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.6. Denmark
      • 7.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.8. Norway
      • 7.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.2. China
      • 7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.3. India
      • 7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.5. Thailand
      • 7.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.6. South Korea
      • 7.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.2. Mexico
      • 7.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Market Participant Categorization
    • 8.2.1. GSK
      • 8.2.1.1. Company overview
      • 8.2.1.2. Financial performance
      • 8.2.1.3. Product benchmarking
      • 8.2.1.4. Strategic initiatives
    • 8.2.2. Novartis/CSL
      • 8.2.2.1. Company overview
      • 8.2.2.2. Financial performance
      • 8.2.2.3. Product benchmarking
      • 8.2.2.4. Strategic initiatives
    • 8.2.3. Agenus
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Product benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. Adjuvance
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Product benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. Novavax
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Product benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. SPI Pharma
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Product benchmarking
      • 8.2.6.4. Strategic initiatives
    • 8.2.7. Invivogen
      • 8.2.7.1. Company overview
      • 8.2.7.2. Financial performance
      • 8.2.7.3. Product benchmarking
      • 8.2.7.4. Strategic initiatives
    • 8.2.8. Avanti Polar Lipids
      • 8.2.8.1. Company overview
      • 8.2.8.2. Financial performance
      • 8.2.8.3. Product benchmarking
      • 8.2.8.4. Strategic initiatives
    • 8.2.9. Brentagg
      • 8.2.9.1. Company overview
      • 8.2.9.2. Financial performance
      • 8.2.9.3. Product benchmarking
      • 8.2.9.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America Vaccine Adjuvants market, by type, 2018 - 2030 (USD Million)
  • Table 3 North America vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
  • Table 4 North America vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
  • Table 5 North America vaccine adjuvants market, by region, 2018 - 2030 (USD Million)
  • Table 6 U.S. vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
  • Table 7 U.S. vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
  • Table 8 U.S. vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
  • Table 9 Canada vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
  • Table 10 Canada vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
  • Table 11 Canada vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
  • Table 12 Europe vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
  • Table 13 Europe vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
  • Table 14 Europe vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
  • Table 15 Europe vaccine adjuvants market, by region, 2018 - 2030 (USD Million)
  • Table 16 Germany vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
  • Table 17 Germany vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
  • Table 18 Germany vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
  • Table 19 UK vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
  • Table 20 UK vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
  • Table 21 UK vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
  • Table 22 France vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
  • Table 23 France vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
  • Table 24 France vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
  • Table 25 Italy vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
  • Table 26 Italy vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
  • Table 27 Italy vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
  • Table 28 Spain vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
  • Table 29 Spain vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
  • Table 30 Spain vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
  • Table 31 Denmark vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
  • Table 32 Denmark vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
  • Table 33 Denmark vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
  • Table 34 Sweden vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
  • Table 35 Sweden vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
  • Table 36 Sweden vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
  • Table 37 Norway vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
  • Table 38 Norway vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
  • Table 39 Norway vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific vaccine adjuvants market, by region, 2018 - 2030 (USD Million)
  • Table 44 Japan vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
  • Table 45 Japan vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
  • Table 46 Japan vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
  • Table 47 China vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
  • Table 48 China vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
  • Table 49 China vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
  • Table 50 India vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
  • Table 51 India vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
  • Table 52 India vaccine adjuvants market, by administration, (USD Million) 2018 - 2030
  • Table 53 Australia vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
  • Table 54 Australia vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
  • Table 55 Australia vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
  • Table 56 Thailand vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
  • Table 57 Thailand vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
  • Table 58 Thailand vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
  • Table 59 South Korea vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
  • Table 60 South Korea vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
  • Table 61 South Korea vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
  • Table 62 Latin America vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
  • Table 63 Latin America vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
  • Table 64 Latin America vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
  • Table 65 Latin America vaccine adjuvants market, by region, 2018 - 2030 (USD Million)
  • Table 66 Brazil vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
  • Table 67 Brazil vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
  • Table 68 Brazil vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
  • Table 69 Mexico vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
  • Table 70 Mexico vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
  • Table 71 Mexico vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
  • Table 72 Argentina vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
  • Table 73 Argentina vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
  • Table 74 Argentina vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
  • Table 75 Middle East and Africa vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
  • Table 76 Middle East and Africa vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
  • Table 77 Middle East and Africa vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
  • Table 78 Middle East and Africa vaccine adjuvants market, by region, 2018 - 2030 (USD Million)
  • Table 79 South Africa vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
  • Table 80 South Africa vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
  • Table 81 South Africa vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
  • Table 85 UAE vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
  • Table 86 UAE vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
  • Table 87 UAE vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
  • Table 88 Kuwait vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
  • Table 89 Kuwait vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
  • Table 90 Kuwait vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 QFD modeling for market share assessment
  • Fig. 6 Market formulation & validation
  • Fig. 7 Vaccine adjuvants: Market outlook
  • Fig. 8 Vaccine adjuvants: Competitive insights
  • Fig. 9 Parent market outlook
  • Fig. 10 Related/ancillary market outlook
  • Fig. 11 Penetration and growth prospect mapping
  • Fig. 12 Industry value chain analysis
  • Fig. 13 Vaccine adjuvants market driver impact
  • Fig. 14 Vaccine adjuvants market restraint impact
  • Fig. 15 Vaccine adjuvants market strategic initiatives analysis
  • Fig. 16 Vaccine adjuvants market: Type movement analysis
  • Fig. 17 Vaccine adjuvants market: Type outlook and key takeaways
  • Fig. 18 Pathogen market estimates and forecasts, 2018 - 2030
  • Fig. 19 Adjuvant emulsion market estimates and forecasts, 2018 - 2030
  • Fig. 20 Particulate market estimates and forecasts, 2018 - 2030
  • Fig. 21 Combination market estimates and forecasts, 2018 - 2030
  • Fig. 22 Others market estimates and forecasts, 2018 - 2030
  • Fig. 23 Vaccine adjuvants market: Application movement analysis
  • Fig. 24 Vaccine adjuvants market: Application outlook and key takeaways
  • Fig. 25 Infectious diseases market estimates and forecasts, 2018 - 2030
  • Fig. 26 Cancer market estimates and forecasts, 2018 - 2030
  • Fig. 27 Others market estimates and forecasts, 2018 - 2030
  • Fig. 28 Vaccine adjuvants market: Administration movement analysis
  • Fig. 29 Vaccine adjuvants market: Administration outlook and key takeaways
  • Fig. 30 Oral market estimates and forecasts, 2018 - 2030
  • Fig. 31 Intradermal market estimates and forecasts, 2018 - 2030
  • Fig. 32 Intranasal market estimates and forecasts, 2018 - 2030
  • Fig. 33 Intramuscular market estimates and forecasts, 2018 - 203
  • Fig. 34 Others market estimates and forecasts, 2018 - 2030
  • Fig. 35 Global vaccine adjuvants market: Regional movement analysis
  • Fig. 36 Global vaccine adjuvants market: Regional outlook and key takeaways
  • Fig. 37 North America market estimates and forecasts, 2018 - 2030
  • Fig. 38 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 39 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 40 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 41 UK market estimates and forecasts, 2018 - 2030
  • Fig. 42 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 43 France market estimates and forecasts, 2018 - 2030
  • Fig. 44 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 45 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 46 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 47 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 48 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 49 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 50 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 51 China market estimates and forecasts, 2018 - 2030
  • Fig. 52 India market estimates and forecasts, 2018 - 2030
  • Fig. 53 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 54 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 55 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 56 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 57 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 58 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 59 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 60 Middle East and Africa. market estimates and forecasts, 2018 - 2030
  • Fig. 61 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 62 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 63 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 64 Kuwait market estimates and forecasts, 2018 - 2030